Clinical Trial Update: A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax [Phase 1]

View source ↗

Summary

Phase I trial evaluating the safety and immunogenicity of PnuBioVax for pneumococcal infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• PnuBioVax

Snippet

Sponsor: ImmunoBiology Limited | Conditions: Pneumococcal Infection | Phase 1 | Status: COMPLETED